$360B Women's Health Ghost Market Report

Amboy Street Ventures invests in Allswell’s $1.3M pre-seed round to advance accessible, culturally competent behavioral healthcare for the LGBTQ+ population.

This week we unpack one of the first major IPOs in digital health, Hinge Health’s debut.

Every year, Amboy Street publishes a series of blogs highlighting ten notable women’s health deals from the past twelve months that reflect the latest trends and major successes.

Amboy Street Ventures is pleased to announce its participation in the $4.6 million seed round for Juniper Genomics, a company transforming care in IVF with the world’s first embryo screening test powered by whole-genome and transcriptome sequencing.

Amboy Street is excited to announce its latest investment in Millie - a midwifery-led, hybrid maternity clinic providing in-person and virtual care.

We analyzed our annual Top 10 Deals blog series from 2021 - 2024 and identified the most active acquirer profiles in women’s health and sexual health.

For our last deal in the Top 10 Deals of 2024 series, we explore a major acquisition in women’s health biopharma - a deal that advances innovation in the treatment of ovarian cancer, one of the deadliest forms of the disease.

Amboy Street Ventures is excited to announce its latest investment in Gesynta Pharma - developing a novel non-hormonal drug candidate for the treatment of endometriosis.

This blog highlights one of the largest growth capital investments made in Femtech this year. Led by General Atlantic, the deal highlights a growing interest in the women’s health sector from prominent generalist firms.